Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Lyra Therapeutics (LYRA) is now available.
Edward T. Anderson has stepped down from his roles on the Board of Directors and its Audit and Compensation Committees at Lyra Therapeutics, Inc., where he has served since 2019, after being an investor and adviser since 2006. The company expressed gratitude for his contributions and appointed Nancy L. Snyderman to the Audit Committee in his stead.
For a thorough assessment of LYRA stock, go to TipRanks’ Stock Analysis page.
